Microcystin-YR

CAS : 101064-48-6

Ref. 3D-FM73137

Informations sur le produit

• Nom: Microcystin-YR
• Synonymes: Microcystin Yr From Microcystis Aeruginosa, Microcystin-Yr Solution, (5R,8R,11R,12S,15S,18S,19S,22R)-15-{3-[(diaminomethylidene)amino]propyl}-8-(4-hydroxybenzyl)-18-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dien-1-yl]-1,5,12,19-tetramethyl-2-methylidene-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptaazacyclopentacosane-11,22-dicarboxylic acid

Description

Microcystin-YR is a polymerase chain inhibitor that blocks the production of RNA. It is used to diagnose cells with resistance to imatinib and dasatinib, which are drugs used in the treatment of chronic myeloid leukemia. Microcystin-YR also inhibits bcr-abl kinase, an enzyme involved in the production of RNA and DNA in cancer cells. This drug has been shown to cause cell lysis, or the breakdown of cells, and has been found to be effective against liver lesions caused by congestive heart failure and skin cancer. It has also been shown to inhibit cyclic peptide synthesis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 1,045.19 g/mol
• Formule: C₅₂H₇₂N₁₀O₁₃
• Degré de pureté: Min. 95%